AVD

doxorubicin, vinblastine, dacarbazine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVD, covering 2017-08-30 to 2023-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma [Phase 2]